BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3680520)

  • 21. [Endoscopic diagnosis of Barrett's esophagus].
    Hoshihara Y; Kogure T; Yamamoto T; Hashimoto M; Hoteya O
    Nihon Rinsho; 2005 Aug; 63(8):1394-8. PubMed ID: 16101228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma.
    Soslow RA; Ying L; Altorki NK
    J Thorac Cardiovasc Surg; 1997 Nov; 114(5):838-43. PubMed ID: 9375615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.
    Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV
    Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
    Soslow RA; Remotti H; Baergen RN; Altorki NK
    Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
    Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of laminins in the basement membranes of the upper gastrointestinal tract and Barrett's oesophagus.
    Dave U; Thursz MR; Ebrahim HY; Burke MM; Townsend ER; Walker MM
    J Pathol; 2004 Mar; 202(3):299-304. PubMed ID: 14991894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of Barrett's oesophagus.
    Van Eyken P
    Acta Gastroenterol Belg; 2000; 63(1):10-2. PubMed ID: 10907312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological and histochemical changes in the columnar lined (Barrett's) oesophagus.
    Rothery GA; Patterson JE; Stoddard CJ; Day DW
    Gut; 1986 Sep; 27(9):1062-8. PubMed ID: 3758820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
    Morales TG; Bhattacharyya A; Johnson C; Sampliner RE
    Am J Gastroenterol; 1997 Oct; 92(10):1818-22. PubMed ID: 9382043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of Barrett's esophagus.
    Chandrasoma P
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Senescence-associated' beta-galactosidase activity in the upper gastrointestinal tract.
    Going JJ; Stuart RC; Downie M; Fletcher-Monaghan AJ; Keith WN
    J Pathol; 2002 Apr; 196(4):394-400. PubMed ID: 11920734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
    DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
    Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma.
    Goda K; Tajiri H; Ikegami M; Urashima M; Nakayoshi T; Kaise M
    Gastrointest Endosc; 2007 Jan; 65(1):36-46. PubMed ID: 17185078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus.
    Su Y; Chen X; Klein M; Fang M; Wang S; Yang CS; Goyal RK
    Lab Invest; 2004 Jun; 84(6):753-65. PubMed ID: 15094711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus.
    Kumble S; Omary MB; Fajardo LF; Triadafilopoulos G
    Int J Cancer; 1996 Mar; 66(1):48-54. PubMed ID: 8608965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.